GOLM1, golgi membrane protein 1, 51280

N. diseases: 100; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0267797
Disease: Acute hepatitis
Acute hepatitis
0.020 AlteredExpression disease BEFREE Several reports also noted the increased levels of GP73 expression in chronic liver disease in patients with acute hepatitis of various etiologies, chronic Hepatitis C virus (HCV) infection and alcoholic liver disease. 24351813 2013
CUI: C0267797
Disease: Acute hepatitis
Acute hepatitis
0.020 AlteredExpression disease BEFREE GP73 expression was detected immunohistochemically and by immunofluorescence microscopy in patients with acute hepatitis of various etiologies, autoimmune hepatitis, chronic HCV infection, and alcoholic liver disease. 15180730 2004
CUI: C3850141
Disease: Acute-On-Chronic Liver Failure
Acute-On-Chronic Liver Failure
0.010 AlteredExpression disease BEFREE Further ELISA analysis confirmed the significant up-regulation of GP73, MMR, OPN and down-regulation of ATIII, HPX, APO-CII in HBV-ACLF plasma samples (<i>p</i> < 0.01). 29270132 2017
CUI: C0279628
Disease: Adenocarcinoma Of Esophagus
Adenocarcinoma Of Esophagus
0.010 Biomarker disease BEFREE We demonstrate that the structure of the Golgi is fragmented and the intracellular localisation of GOLPH2 is altered in BO and oesophageal adenocarcinoma tissue. 26461057 2015
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.310 Biomarker disease BEFREE Based on these findings, we infer that GOLM1 might serve as a valuable prognostic biomarker in LUAD, but not in LUSC. 29843532 2018
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.310 Biomarker disease CTD_human c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma. 27602772 2016
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.010 Biomarker disease BEFREE GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway. 30935831 2019
CUI: C0279607
Disease: Adult Hepatocellular Carcinoma
Adult Hepatocellular Carcinoma
0.010 Biomarker disease BEFREE Effect of GP73 silencing on proliferation and apoptosis in hepatocellular cancer. 25170213 2014
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.030 Biomarker disease BEFREE Golgi Protein 73 (GP73) is a newly identified diagnostic and prognostic marker for liver cancer. 29552166 2018
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.030 Biomarker disease BEFREE The results proved that the novel GOLPH2-regulated GD55 conferred higher adenovirus replication and infectivity for liver cancer cells than oncolytic adenovirus ZD55. 25980438 2015
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.030 Biomarker disease BEFREE GP73 has drawn increasing attention for its potential application in the diagnosis of liver diseases such as hepatitis, liver cirrhosis and liver cancer. 30341783 2019
CUI: C0023896
Disease: Alcoholic Liver Diseases
Alcoholic Liver Diseases
0.020 AlteredExpression group BEFREE Several reports also noted the increased levels of GP73 expression in chronic liver disease in patients with acute hepatitis of various etiologies, chronic Hepatitis C virus (HCV) infection and alcoholic liver disease. 24351813 2013
CUI: C0023896
Disease: Alcoholic Liver Diseases
Alcoholic Liver Diseases
0.020 AlteredExpression group BEFREE Increased levels of GP73 expression were also noted in chronic HCV infection and alcoholic liver disease. 15180730 2004
CUI: C1865868
Disease: ALZHEIMER DISEASE 5
ALZHEIMER DISEASE 5
0.010 AlteredExpression disease BEFREE Transfection of GP73-SphK1sR-Ad5 significantly upregulated E1A and downregulated SphK1 in Huh7 cells, but not in HL7702 cells. 31749347 2020
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.030 GeneticVariation disease BEFREE A polymorphism, rs10868366, in the Golgi phosphoprotein 2 gene, GOLM1, was recently identified as an AD risk factor in a genome-wide association study. 20570408 2012
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.030 Biomarker disease BEFREE We found no evidence of association between GOLPH2 markers and susceptibility to Alzheimer's disease in our series. 19749441 2009
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.030 GeneticVariation disease BEFREE Genomewide association (GWA) studies have recently implicated 4 novel Alzheimer disease (AD) susceptibility loci (GAB2, GOLM1, and 2 uncharacterized loci to date on chromosomes 9p and 15q). 19204163 2009
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
0.010 AlteredExpression disease BEFREE The growth and motility of the PDAC cells was enhanced following overexpression of GOLPH2, whereas downregulating the expression of GOLPH2 impaired the growth, motility and tumorigenesis. 29344673 2018
CUI: C0241910
Disease: Autoimmune Chronic Hepatitis
Autoimmune Chronic Hepatitis
0.010 AlteredExpression disease BEFREE Treatment of autoimmune hepatitis was associated with a normalization of GP73 expression, indicating that the initial upregulation was reversible. 15180730 2004
CUI: C4721555
Disease: Autoimmune hepatitis
Autoimmune hepatitis
0.010 AlteredExpression disease BEFREE Treatment of autoimmune hepatitis was associated with a normalization of GP73 expression, indicating that the initial upregulation was reversible. 15180730 2004
CUI: C0004763
Disease: Barrett Esophagus
Barrett Esophagus
0.010 Biomarker disease BEFREE We demonstrate that the structure of the Golgi is fragmented and the intracellular localisation of GOLPH2 is altered in BO and oesophageal adenocarcinoma tissue. 26461057 2015
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.010 Biomarker disease BEFREE These results suggest that GP73 promotes bladder cancer invasion and metastasis by inducing the EMT through down-regulating WT1 levels and activating the TGF-β1/Smad2 signalling pathway. 29349903 2018
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.020 Biomarker disease BEFREE Using five bioinformatics analysis software, we identified Golgi protein 73 (GP73) as a putative target of microRNA-27b (miR-27b), which is closely related to various biological processes or diseases such as bone metabolism disease, adipose cell and muscle cell development, pulmonary hypertension, cervical cancer, and breast cancer. 30418194 2019
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.020 AlteredExpression disease BEFREE MATERIAL AND METHODS The expression of GOLM1 in BC tissues and cell lines was detected by using qRT-PCR assay. 30695018 2019
CUI: C0877445
Disease: Candidemia
Candidemia
0.010 GeneticVariation disease BEFREE Among them, a cytokine QTL at the NAA35-GOLM1 locus markedly modulated interleukin (IL)-6 production in response to multiple pathogens and was associated with susceptibility to candidemia. 27376574 2016